Longitude Prime
Startup rounds since 2014 with a Longitude Prime investor on the board, and the firm's own fund filings.
Raises
34
since 2014
Unannounced
1
no announcement found, of those filed since 2025
Funds
2
fund filings under the firm's name
Rounds
- Infinant Health, Inc.$39.2M
- Veradermics, Inc$135M
- VeraDermics, Inc$66.6M
- CuraSen Therapeutics, Inc.$5.79M
- Zenas BioPharma, Inc.$200M
- Endeavor Biomedicines, Inc.$133M
- BioAge Labs, Inc.$194M
- CuraSen Therapeutics, Inc.$17.6M
- Endeavor Biomedicines, Inc.$89.1M
- CuraSen Therapeutics, Inc.$18M
- Rivus Pharmaceuticals, Inc.$34.5M
- Vera Therapeutics, Inc.$70.7M
- Orbus Therapeutics, Inc.$10M
- SutroVax, Inc.$110M
- Orbus Therapeutics, Inc.$18.5M
- CuraSen Therapeutics, Inc.$27.2M
- Aimmune Therapeutics, Inc.$98M
- SutroVax, Inc.$43.2M
- Aimmune Therapeutics, Inc.$157M
- Aptinyx Inc.$70M
- Infacare Pharmaceutical Corp$3.5M
- SutroVax, Inc.$40.1M
- Cardiodx Inc$18.1M
- Infacare Pharmaceutical Corp$5.5M
- Aptinyx Inc.$25M
- Cardiodx Inc$12.4M
- Orbus Therapeutics, Inc.$18M
- SutroVax, Inc.$12.6M
- Infacare Pharmaceutical Corp$12.1M
- Allergen Research Corp$80M
- Infacare Pharmaceutical Corp$1.3M
- Infacare Pharmaceutical Corp$750K
- Cardiodx Inc$21M
- Esperion Therapeutics, Inc.Undisclosed
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 1 | 1 |
| 2025 | 1 | 0 |
| 2024 | 5 | — |
| 2023 | 1 | — |
| 2022 | 1 | — |
| 2021 | 3 | — |
| 2020 | 2 | — |
| 2019 | 2 | — |
| 2018 | 3 | — |
| 2017 | 4 | — |
| 2016 | 3 | — |
| 2015 | 4 | — |
| 2014 | 4 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Longitude Prime Fund II, L.P. | 20 Jul 2023 | $200M | $49.9M |
| Longitude Prime Fund, L.P. | 17 Jun 2021 | $130M | — |
Listed because a Longitude Prime fund's filing names a director of each company. A name match is not a verified identity.